Скачать или смотреть TAKHZYRO® For Loved Ones- 30 seconds

Intended for US Audiences ​

See TAKHZYRO’s Full Prescribing Information here: https://www.shirecontent.com/PI/PDFs/...

TAKHZYRO Important Safety Information: https://www.takhzyro.com/#isi
HAE runs in their family. So could the TAKHZYRO experience. Learn about the hereditary nature of HAE and talk to your doctor about TAKHZYRO and if it may be an option for you and your loved ones.

Learn More: https://www.takhzyro.com/why-takhzyro...

What is TAKHZYRO?

TAKHZYRO (lanadelumab-flyo) is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in people 2 years of age and older.
It is not known if TAKHZYRO is safe and effective in children under 2 years of age.

IMPORTANT SAFETY INFORMATION

TAKHZYRO may cause serious side effects, including allergic reactions. Call your healthcare provider or get emergency help right away if you have any of the following symptoms:

wheezing
difficulty breathing
chest tightness
fast heartbeat
faintness
rash
hives

The most common side effects seen with TAKHZYRO were injection site reactions (pain, redness, and bruising), upper respiratory infection, headache, rash, dizziness, diarrhea, and muscle aches.

These are not all the possible side effects of TAKHZYRO. For more information, ask your healthcare provider or pharmacist. You may report side effects to FDA at 1‑800‑FDA‑1088.

TAKHZYRO has not been studied in pregnant or breastfeeding women. Talk to your healthcare provider about the risk of taking TAKHZYRO if you are pregnant, plan to be pregnant, are breastfeeding, or plan to breastfeed.

Please see full Prescribing Information, including information for patients: https://www.shirecontent.com/PI/PDFs/...
Takeda does not control any AI on the platform and is not responsible or liable for user-generated content via AI.

US-LANA-2430v1.0 10/25